News

POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES
Domain expertise, global resource, long-term capital
PORTFOLIO NEWS
Impact Therapeutics Entered into Global Partnership with Eikon Therapeutics to Develop and Commercialize PARP1 Selective Inhibitors
2023年6月2日
SHANGHAI, China and HAYWARD, Calif., June 1, 2023 – IMPACT Therapeutics (“Impact”), a...
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis
2023年5月15日
SHANGHAI, May 15, 2023 /PRNewswire/ -- Rona Therapeutics, Inc ("Rona") and Keymed Biosciences...
Alebund Pharmaceuticals Closes Nearly RMB 200 Million Pre-C Round Financing and Secures RMB 800 Million Syndicated Loan Credit
2023年4月12日
Shanghai, China, April 12th, 2023—Alebund Pharmaceuticals (“Alebund” or the “Company”)...
IMPACT Therapeutics Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment Following First-line Therapy Met Primary Endpoint
2023年4月12日
SHANGHAI, China, April 11, 2023 -- IMPACT Therapeutics, Inc. (“IMPACT Therapeutics”),...
BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors
2023年4月4日
BioNTech receives exclusive licenses from DualityBio for two investigational antibody-drug...
ArriVent Biopharma Closes $155 Million Oversubscribed Series B Financing
2023年3月28日
Funding from new and existing investors will support pivotal Phase 3 and additional studies...
China’s NMPA Clears Phase 3 IND Application for Alebund Pharmaceutical’s AP301, a New-generation Iron-based Phosphate Binder, to Treat Hyperphosphatemia in Dialysis Patients
2023年3月17日
March 17, 2023, Shanghai, China—Alebund Pharmaceuticals (“Alebund” or the “Company”) announced...
Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology
2023年2月28日
SUZHOU, China and SAN FRANCISCO, Feb. 27, 2023 /PRNewswire/ -- Eluminex Biosciences (Suzhou)...
More Posts

POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES

Domain expertise, global resource, long-term capital

PORTFOLIO NEWS